Literature DB >> 10197733

Neurotransmitters, peptides, and neural cell adhesion molecules in the cortices of normal elderly humans and Alzheimer patients: a comparison.

D T Yew1, W P Li, S E Webb, H W Lai, L Zhang.   

Abstract

Immunocytochemical techniques was used to compare the proportion of neurons expressing various neurotransmitters (tyrosine hydroxylase, choline acetyltransferase and gamma-aminobutyric acid), neuropeptides (Leu-enkephalin and substance P) and neural cell adhesion molecules (NCAM) in the hippocampus, frontal (area 10) and occipital (area 17) cortices of neurologically normal elderly humans to that of age-matched Alzheimer disease (AD) patients. There was no difference in the proportion of GABAergic and cholinergic cells between the normal and AD groups in all three brain regions studied. However, the catecholaminergic cells in the frontal cortex of the AD patients revealed a significant decrease. The catecholaminergic cells present in the cortex were both neurons and astrocytes, as revealed by a double immunostaining of tyrosine hydroxylase and glial fibrillary acid protein (GFAP). Furthermore, the difference in the proportion of cells expressing Substance P and Leu-enkephalin was minimal between the two groups studied. Although there was little difference in the levels of NCAM in the occipital cortex and hippocampus of the two groups, there were significantly fewer positive NCAM neurons in the frontal cortex of AD than normal aging individuals.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10197733     DOI: 10.1016/s0531-5565(98)00017-5

Source DB:  PubMed          Journal:  Exp Gerontol        ISSN: 0531-5565            Impact factor:   4.032


  12 in total

1.  Localization of 5-HT1A and 5-HT2A positive cells in the brainstems of control age-matched and Alzheimer individuals.

Authors:  L Y Yeung; H F Kung; David T Yew
Journal:  Age (Dordr)       Date:  2010-05-28

2.  Restoration of synaptic plasticity and learning in young and aged NCAM-deficient mice by enhancing neurotransmission mediated by GluN2A-containing NMDA receptors.

Authors:  Gaga Kochlamazashvili; Olena Bukalo; Oleg Senkov; Benedikt Salmen; Rita Gerardy-Schahn; Andreas K Engel; Melitta Schachner; Alexander Dityatev
Journal:  J Neurosci       Date:  2012-02-15       Impact factor: 6.167

Review 3.  The mammalian tachykinin ligand-receptor system: an emerging target for central neurological disorders.

Authors:  Nick Pantaleo; Wayne Chadwick; Sung-Soo Park; Liyun Wang; Yu Zhou; Bronwen Martin; Stuart Maudsley
Journal:  CNS Neurol Disord Drug Targets       Date:  2010-11       Impact factor: 4.388

4.  Serum Markers of Neurodegeneration in Maple Syrup Urine Disease.

Authors:  Giselli Scaini; Tássia Tonon; Carolina F Moura de Souza; Patricia F Schuk; Gustavo C Ferreira; Joao Seda Neto; Tatiana Amorin; Ida Vanessa D Schwartz; Emilio L Streck
Journal:  Mol Neurobiol       Date:  2016-09-22       Impact factor: 5.590

5.  Serotonin 5-HT2A and 5-HT6 receptors in the prefrontal cortex of Alzheimer and normal aging patients.

Authors:  Dietrich E Lorke; Gang Lu; Eric Cho; David T Yew
Journal:  BMC Neurosci       Date:  2006-04-27       Impact factor: 3.288

Review 6.  GABAergic neurotransmission and new strategies of neuromodulation to compensate synaptic dysfunction in early stages of Alzheimer's disease.

Authors:  Mauricio O Nava-Mesa; Lydia Jiménez-Díaz; Javier Yajeya; Juan D Navarro-Lopez
Journal:  Front Cell Neurosci       Date:  2014-06-25       Impact factor: 5.505

Review 7.  Synaptic Cell Adhesion Molecules in Alzheimer's Disease.

Authors:  Iryna Leshchyns'ka; Vladimir Sytnyk
Journal:  Neural Plast       Date:  2016-05-03       Impact factor: 3.599

8.  Brain structure, cognition and negative symptoms in schizophrenia are associated with serum levels of polysialic acid-modified NCAM.

Authors:  F Piras; M Schiff; C Chiapponi; P Bossù; M Mühlenhoff; C Caltagirone; R Gerardy-Schahn; H Hildebrandt; G Spalletta
Journal:  Transl Psychiatry       Date:  2015-10-13       Impact factor: 6.222

Review 9.  Towards a Better Understanding of GABAergic Remodeling in Alzheimer's Disease.

Authors:  Karan Govindpani; Beatriz Calvo-Flores Guzmán; Chitra Vinnakota; Henry J Waldvogel; Richard L Faull; Andrea Kwakowsky
Journal:  Int J Mol Sci       Date:  2017-08-21       Impact factor: 5.923

10.  Increased Levels of Brain Adrenomedullin in the Neuropathology of Alzheimer's Disease.

Authors:  Hilda Ferrero; Ignacio M Larrayoz; Eva Martisova; Maite Solas; David R Howlett; Paul T Francis; Francisco J Gil-Bea; Alfredo Martínez; María J Ramírez
Journal:  Mol Neurobiol       Date:  2017-09-02       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.